Aprecia Pharmaceuticals brings in $35M to move forward with 3D printed dissolving drug pipeline
Aprecia Pharmaceuticals is getting closer to commercializing SPRITAM, its 3D printed formulation of levetiracetam, which is a well-established medication used by patients with epilepsy.